This on-demand webinar offers an in-depth look at Upperton’s integrated capabilities, from early-stage development to commercial manufacturing, with a special focus on their new sterile facility and end-to-end project support.
Webinar overview
Join Ian Lafferty, Chief Technical Officer, and Josh Moule, Business Development Manager, as they present Upperton’s comprehensive CDMO services. This webinar explores how Upperton supports clients across the full clinical development pathway, from pre-clinical formulation to commercial readiness.
Key topics covered
• Upperton’s full-service CDMO model and flexible project management approach
• Formulation development expertise across oral, nasal, pulmonary, and sterile dosage forms
• R&D capabilities including material characterization, prototype development, and enabling technologies like spray drying
• Analytical and QC services supporting method development and stability testing
• An overview of Upperton’s new 7,000 sq ft sterile facility designed to meet EU GMP Annex 1 requirements
• Manufacturing scalability from early-phase clinical supply to niche commercial production
• Case study insights into aseptic fill/finish capabilities for liquids, suspensions, and powders
Speakers
Ian Lafferty
Chief Technical Officer, Upperton Pharma Solutions
Josh Moule
Business Development Manager, Upperton Pharma Solutions